Showing results (121-130 of 157) with videos related to
Sort By:
Pageof 16
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 11, 2019
Whole brain radiotherapy with concurrent temozolomide in multifocal and/or multicentric newly diagnosed glioblastomaL Lahmi, A Idbaih, E Rivin Del Campo, et al.Genomics|May 1, 1991
Parental origin of chromosome 22 loss in sporadic and NF2 neuromasB Fontaine, M Sanson, O Delattre, et al.Neurology|February 21, 2008
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebriG Kaloshi, S Everhard, F Laigle-Donadey, et al.Journal of Neuro-Oncology|December 1, 2017
Spinal ependymomas in NF2: a surgical disease?M Kalamarides, W Essayed, J P Lejeune, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapyW H Wilson, S E Bates, A Fojo, et al.European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancérologie CutanéeJ J Grob, J Regis, R Laurans, et al.British Journal of Cancer|December 17, 2003
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude miceP Leuraud, L Taillandier, L Aguirre-Cruz, et al.Neuropathology and Applied Neurobiology|January 7, 2005
Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassificationK Mokhtari, S Paris, L Aguirre-Cruz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomasW H Wilson, B A Chabner, G Bryant, et al.Stem Cells (Dayton, Ohio)|January 1, 1996
Clinical reversal of multidrug resistanceS E Bates, W H Wilson, A T Fojo, et al.Pageof 16